CogState

CogState Shares Outstanding

The The number of shares of CogState (CGS.AX) as of Oct 17, 2026 is 174.01 M. In the previous year, The number of shares was 174.01 M — a change of 0.00% (lower).

Shares Outstanding

174.01 M

YoY

0.00%

Last updated:

In 2025, CogState had 174.01 M outstanding stocks, a 0.00% change from the 174.01 M stocks in the previous year.

The CogState Shares Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Shares Outstanding
Date
Shares Outstanding
Jan 1, 2023
174.01 M USD
Jan 1, 2024
174.01 M USD
Jan 1, 2025
174.01 M USD
Jan 1, 2026 (e)
174.01 USD
Jan 1, 2027 (e)
174.01 USD
Jan 1, 2028 (e)
174.01 USD
Jan 1, 2029 (e)
174.01 USD
Jan 1, 2030 (e)
174.01 USD
The CogState Shares Outstanding history
YEARShares OutstandingYoY
est174.010.00%
est174.010.00%
est174.010.00%
est174.010.00%
est174.01-100.00%
174.01 M0.00%
174.01 M0.00%
174.01 M0.00%
174.01 M0.00%
174.01 M0.00%
174.01 M0.00%
174.01 M0.00%
174.01 M0.00%
174.01 M0.00%
174.01 M0.00%
174.01 M0.00%
174.01 M+225.46 M%
77.18+1.93%
75.72+12.13%
67.53-4.10%
70.42+6.39%
66.19+29.28%
51.20-3.38%
52.99+33.95%
39.56—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CogState Number of shares

CogState shares outstanding

The number of shares of CogState was 174.01 M in 2025. This indicates how many shares CogState is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2023
176.34 M Stocks
Jan 1, 2024
173.10 M Stocks
Jan 1, 2025
174.01 M Stocks
Jan 1, 2026 (e)
174.01 M Stocks
Jan 1, 2027 (e)
174.01 M Stocks
Jan 1, 2028 (e)
174.01 M Stocks
Jan 1, 2029 (e)
174.01 M Stocks
Jan 1, 2030 (e)
174.01 M Stocks

CogState Stock analysis

What does CogState do? CogState Ltd is an Australian company specializing in the development of innovative cognitive tests. The company was founded in 1999 and is based in Melbourne, Australia. It conducts computer-based cognitive tests to gather information about the cognitive functioning of patients and athletes. The CogState tests are specifically designed to measure cognitive abilities in areas such as perception, reaction time, memory, and attention. The business model of CogState is based on the development, marketing, and sale of cognitive test products. The company generates a significant portion of its revenue through licensing its tests to pharmaceutical and biotech companies that want to test their medications or therapies more effectively. CogState also has a strong presence in the sports industry, offering its tests to sports teams and individual athletes. CogState was founded in 1999 by Paul Maruff, a neuropsychologist, who was searching for better and more effective ways to conduct cognitive tests. Initially, the tests developed by CogState were exclusively for medical research, but it was quickly discovered that they could be useful in other areas as well. In 2004, Richard Kimber joined the company as CEO and Chairman, bringing his experience from the biotechnology industry. CogState offers a variety of cognitive tests for various applications, including clinical trials, sports performance analysis, and brain injury treatment. The tests are licensed by different companies and organizations that use them to test the effects of medications and therapies on cognitive functions or to assess performance and injuries in sports. One example of a CogState product is the AX Continuous Tracker Test. This test was developed for clinical use and allows for continuous and accurate measurement of cognitive functions in patients with psychiatric and neurological disorders. Another application is the SPARQ test for athletes, which allows for the measurement and improvement of athletes' cognitive abilities. In summary, CogState Ltd is a leading company in the field of cognitive tests. The company specializes in developing innovative cognitive tests for the specific requirements of pharmaceutical and biotech companies, as well as sports organizations. The tests are used worldwide by various organizations and have a significant impact on the treatment of psychiatric and neurological disorders, as well as performance and injury analysis in sports. CogState is one of the most popular companies on Eulerpool.

Shares Outstanding Details

Evaluating CogState's Shares Outstanding

CogState's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in CogState’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding CogState’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in CogState’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about CogState stock

The number of shares of CogState is 174.01 M in 2025.

The number of shares of CogState changed from 174.01 M to 174.01 M, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The number of shares CogState since 2006 – with annual values, charts, and detailed analysis.

The number of shares indicates the total number of a company's shares. This includes not only the shares available on the market, but also the shares held by shareholders and the shares retained by the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — CogState

All Key Metrics — CogState